Effect of early tranexamic acid treatment on fatigue in patients with mild traumatic brain injury: data from the CRASH-3 clinical trial (2021)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.17421.1
Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.17421.1
Type: Journal Article/Review
Parent Publication: Wellcome Open Research